Page last updated: 2024-11-05

troglitazone and Adenoma, beta-Cell

troglitazone has been researched along with Adenoma, beta-Cell in 2 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research Excerpts

ExcerptRelevanceReference
"Insulinoma cell line beta-cell (INS-1 cells) were treated with PPARalpha ligand (clofibrate) and PPARgamma ligands (troglitazone and thiazolidinedione)."3.72[The effect of peroxisome proliferator-activated receptor alpha and gamma ligands on free fatty acid-induced INS-1 cell impairment]. ( Chen, ZJ; Yang, LY; Yang, YN, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, LY1
Yang, YN1
Chen, ZJ1
Kawai, T1
Hirose, H1
Seto, Y1
Fujita, H2
Ukeda, K1
Saruta, T1

Other Studies

2 other studies available for troglitazone and Adenoma, beta-Cell

ArticleYear
[The effect of peroxisome proliferator-activated receptor alpha and gamma ligands on free fatty acid-induced INS-1 cell impairment].
    Zhonghua nei ke za zhi, 2003, Volume: 42, Issue:12

    Topics: Animals; Anticholesteremic Agents; Apoptosis; Cell Line, Tumor; Chromans; Clofibrate; Fatty Acids, N

2003
Troglitazone ameliorates lipotoxicity in the beta cell line INS-1 expressing PPAR gamma.
    Diabetes research and clinical practice, 2002, Volume: 56, Issue:2

    Topics: Animals; Base Sequence; Cell Division; Cell Survival; Chromans; DNA Primers; Fatty Acids, Nonesterif

2002